Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab
‘Where the product in question is a life-saving drug, the Court has to err in favour of public interest’, said the bench The Delhi High Court on Monday cleared the…
Zydus Lifesciences gets USFDA nod for Leuprolide Acetate injection
Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator for its generic version of Leuprolide Acetate injection used in palliative treatment of advanced…
ZyVet releases generic treatment for Canine Urinary Incontinence in US
Pennington: ZyVet Animal Health, a generic pharmaceuticals company for animals, a wholly owned subsidiary of Zydus Pharmaceuticals (USA) Inc., itself a wholly owned subsidiary of Zydus Lifesciences Ltd., a global…
Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million
Zydus Lifesciences plans to acquire Nasdaq-listed clinical-stage immuno-oncology firm Agenus’s two biologics manufacturing facilities in California, U.S. for $125 million to enter the global biologics contract development and manufacturing organization…
Indian pharma stocks tumble as Trump signals tariffs on drug imports
Indian pharmaceutical stocks slumped on Wednesday after US President Donald Trump renewed his threat to impose sweeping tariffs on all pharmaceutical imports, an announcement that sent shockwaves through drug industry…
Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company
Zydus Lifesciences has announced a significant agreement with CVS Caremark, a CVS Health company, to include Zituvio™, Zituvimet™, and Zituvimet™ XR in its template formulary starting January 2025. These products,…
